Japan Tissue Engineering Co., Ltd. (TYO:7774)

Japan flag Japan · Delayed Price · Currency is JPY
556.00
+2.00 (0.36%)
At close: Feb 6, 2026
22.74%
Market Cap22.58B +17.5%
Revenue (ttm)2.26B -7.2%
Net Income-461.45M
EPS-11.36
Shares Out40.61M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume129,400
Average Volume174,750
Open574.00
Previous Close554.00
Day's Range555.00 - 574.00
52-Week Range361.00 - 749.00
Beta0.27
RSI54.98
Earnings DateJan 30, 2026

About Japan Tissue Engineering

Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Contract, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in th... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 204
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7774
Full Company Profile

Financial Performance

Financial Statements